{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T04:47:32Z","timestamp":1771994852777,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jval.2017.04.015","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T11:00:19Z","timestamp":1496401219000},"page":"1034-1040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists"],"prefix":"10.1016","volume":"20","author":[{"given":"Sasha","family":"van Katwyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-ping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham E.","family":"Trope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Buys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Masucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Wedge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Brent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif","family":"El-Defrawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Anh","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kednapa","family":"Thavorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2017.04.015_bib1","unstructured":"Canadian National Institute for the Blind (CNIB). Paying the price: what vision loss costs Canadians and what we should do about it. Available from: http:\/\/www.cnib.ca\/eng\/CNIB%20Document%20Library\/Research\/Paying_the_Price.pdf."},{"key":"10.1016\/j.jval.2017.04.015_bib2","unstructured":"Canadian Diabetes Association. Diabetes in Canada. Available from: https:\/\/www.diabetes.ca\/getmedia\/513a0f6c-b1c9-4e56-a77c-6a492bf7350f\/diabetes-charter-backgrounder-national-english.pdf.aspx"},{"key":"10.1016\/j.jval.2017.04.015_bib3","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/jama.298.8.902","article-title":"Management of diabetic retinopathy: a systematic review","volume":"298","author":"Mohamed","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2017.04.015_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1464-5491.2000.00250.x","article-title":"Effectiveness of screening and monitoring tests for diabetic retinopathy\u2014a systematic review","volume":"17","author":"Hutchinson","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.jval.2017.04.015_bib5","first-page":"S1","article-title":"Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"37","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jval.2017.04.015_bib6","unstructured":"General practice management of type 2 diabetes\u20142014\u201315. Melbourne, Australia: The Royal Australian College of General Practitioners and Diabetes Australia, 2014."},{"key":"10.1016\/j.jval.2017.04.015_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archophthalmol.2010.319","article-title":"Screening for presence or absence of diabetic retinopathy: a meta-analysis","volume":"129","author":"Bragge","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jval.2017.04.015_bib8","article-title":"Lack of government-funded optometric services is associated with reduced utilization of eye care providers and increased utilization of family doctors","author":"Jin","year":"2014","journal-title":"CAHSPR Conference"},{"key":"10.1016\/j.jval.2017.04.015_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1464-5491.2009.02870.x","article-title":"Diabetic retinopathy screening: a systematic review of the economic evidence","volume":"27","author":"Jones","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.jval.2017.04.015_bib10","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2337\/dc10-0843","article-title":"Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review","volume":"33","author":"Li","year":"2010","journal-title":"Diabetes Care."},{"key":"10.1016\/j.jval.2017.04.015_bib11","article-title":"Prince Edward Island: population projections 2014\u20132053","year":"2014","journal-title":"Charlottetown, PEI: Department of Finance and Municipal Affairs"},{"key":"10.1016\/j.jval.2017.04.015_bib12","first-page":"1","article-title":"The evolution and natural history of diabetic retinopathy","volume":"18","author":"Kohner","year":"1978","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.jval.2017.04.015_bib13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-5491.2003.01019.x","article-title":"Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan","volume":"20","author":"Liu","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.jval.2017.04.015_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1474651413495703","article-title":"Mortality in Type 2 Diabetes mellitus: magnitude of the evidence from a systematic review and meta-analysis","volume":"13","author":"Chukwuemaka","year":"2013","journal-title":"Br J Diabetes Vasc Dis"},{"key":"10.1016\/j.jval.2017.04.015_bib15","series-title":"Canadian Vital Statistics, Deaths Database, 2009, Survey 3233 and Demography Division, demographic estimates","year":"2009"},{"key":"10.1016\/j.jval.2017.04.015_bib16","series-title":"Most recent eye exam, diabetic population aged 18 or older. Health report: diabetes\u2014prevalence and care practices. 2005 Canadian Community Health Survey","year":"2005"},{"key":"10.1016\/j.jval.2017.04.015_bib17","doi-asserted-by":"crossref","first-page":"E167","DOI":"10.1503\/cmaj.120862","article-title":"Unintended consequences of delisting routine eye exams on retinopathy screening for people with diabetes in Ontario, Canada","volume":"185","author":"Kiran","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.jval.2017.04.015_bib18","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1001\/archopht.122.11.1631","article-title":"Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69","volume":"122","author":"Matthews","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jval.2017.04.015_bib19","series-title":"Health economic aspects of diabetic retinopathy","author":"Heintz","year":"2012"},{"key":"10.1016\/j.jval.2017.04.015_bib20","series-title":"Master agreement between the Medical Society of Prince Edward Island and the Government of Prince Edward Island and Health PEI. April 1, 2010 \u2013 March 31, 2015","author":"Health","year":"2015"},{"key":"10.1016\/j.jval.2017.04.015_bib21","series-title":"Guidelines for the Economic Evaluation of Health Technologies: Canada","year":"2006"},{"key":"10.1016\/j.jval.2017.04.015_bib22","series-title":"Submission to the Commission on the Future of Health Care in Canada","author":"Anderson","year":"2002"},{"key":"10.1016\/j.jval.2017.04.015_bib23","unstructured":"Canadian Institute for Health Information (CIHI). Diabetes care gaps and disparities in Canada, 2009. Available from: https:\/\/secure.cihi.ca\/free_products\/Diabetes_care_gaps_disparities_aib_e.pdf."},{"key":"10.1016\/j.jval.2017.04.015_bib24","unstructured":"Canadian Diabetes Association. An economic tsunami: the cost of diabetes in Canada. Available from: https:\/\/www.diabetes.ca\/CDA\/media\/documents\/publications-and-newsletters\/advocacy-reports\/economic-tsunami-cost-of-diabetes-in-canada-english.pdf."},{"key":"10.1016\/j.jval.2017.04.015_bib25","unstructured":"Statistics Canada. Health status statistics: diabetes. Available from: http:\/\/www.statcan.gc.ca\/pub\/82-229-x\/2009001\/status\/dia-eng.htm [Accessed September 5, 2016]."},{"key":"10.1016\/j.jval.2017.04.015_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jcjo.2011.06.006","article-title":"The cost of vision loss in Canada","volume":"46","author":"Cruess","year":"2011","journal-title":"Can J Ophthalmol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301517302152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301517302152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T05:58:00Z","timestamp":1535781480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301517302152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1098301517302152"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2017.04.015","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2017.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}